OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-based biomechanical implant design. The Company thoughtfully designed its flagship Apex Tibial and Femoral Nails with a focus on fundamental principles of bone healing, all while keeping the surgeon’s needs in mind. Every OrthoXel product features innovative locking modes not found in any other implant system on the market and all are meticulously designed and engineered to produce the best possible clinical results for every patient.
Among the many topics covered Q218 Trauma Market Recap are:
SmartTRAK's Trauma & Extremities Fixations Sr. Analyst Natasha Weeks identified several key product trends at the Orthopaedic Trauma Association’s (OTA) 33rd Annual Meeting in Vancouver, BC Oct. 11-14, 2017, as manufacturers looked to differentiate themselves and gain share in the US Trauma market, projected to reach over $2.2B by 2021.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.
Despite slightly tougher US comps in Q4, the Trauma Market ended 2017 with steady, mid-single-digit growth primarily driven from the IM Nailing segment. The strength of the IM Nailing segment has been a multi-year story as a result of trauma market leader DePuy Synthes’ TFNA Nail boosting sales each quarter. Other players such as Smith & Nephew and Zimmer Biomet have followed suit touting their own hip and femur nails as growth drivers during the quarter ...
New products and players, along with healthy international sales, gave the Trauma Market a boost in Q317.
By Natasha Weeks, Managing Editor/Sr. Analyst Trauma & Extremities
Strong US growth supported by healthy international sales helped propel the WW Trauma Market up in Q317 – the second quarter with growth. Despite more difficult comps, the trauma segment continued to post yet another quarter of steady growth. IM Nailing, the segment powerhouse, led the charge while Plates & Screws followed suit.
At the 2017 Orthopedic Summit (OSET) meeting in Las Vegas, Mark Foster, Trice Medical’s Chief Commercialization Officer and VP of Worldwide Sales, spoke with SmartTRAK's Kristina Meyer about the Company’s revolutionary new technology that is improving the way orthopedic injuries are diagnosed. Trice Medical’s newest product, mi-eye 2, is a fully disposable, integrated camera (the size of a 14-gauge needle) with plug-and-play technology that is FDA cleared to provide illumination and visualization during diagnostic and operative arthroscopic and endoscopic procedures. These procedures can be performed in the clinic setting and provide patients with immediate and definitive diagnoses while significantly reducing the overall cost to the healthcare system.
A transcript of SmartTRAK’s interview with Trice Medical is below, as is the video interview, recorded live at the 2017 OSET meeting: (11:27 min.)
SmartTRAK's President & CEO Sharon O'Reilly attended DKOU2017, the German Congress of Orthopedic and Trauma Surgery, in Berlin Oct. 24-27, 2017 and uncovered several new and innovative orthopedic, trauma and spine technologies on the exhibit floor.
This week, the SmartTRAK blog is featuring video interviews from DKOU highlighting new companies and products emerging from Europe.
Next up ...
Leanna Caron, EVP & CCO and Dr. James Howe, Founder & CMO - AgNovos Healthcare: A minimally invasive injectable technique for stabilizing osteoporotic hips